[Hiring] Senior Recruiter @4D Molecular Therapeutics

Role Description

The Senior Recruiter is responsible for driving full-cycle recruitment across 4DMT, partnering closely with hiring managers and Associate Director, Talent Acquisition to deliver high-quality talent aligned with the company’s growth objectives. This role supports execution of the Talent Acquisition strategy, manages external and ensures a consistent, efficient, and high-caliber hiring process. The Senior Recruiter will play a critical role in sourcing, engaging, and closing top talent in a competitive biotech market.

Responsibilities

• Manage full-cycle recruitment for assigned roles, including sourcing, screening, interviewing, and offer negotiation.
• Partner with hiring managers to understand hiring needs, define role requirements, and develop candidate profiles.
• Proactively source and engage candidates using a variety of channels, including LinkedIn Recruiter and networking.
• Draft and refine job descriptions in partnership with HR and Total Rewards, ensuring alignment with leveling and compensation frameworks.
• Coordinate and drive interview processes, including scheduling, debrief facilitation, and delivery of structured feedback.
• Support offer development and negotiation in alignment with company compensation philosophy.
• Partner with external search firms and staffing agencies as needed; help ensure quality and cost-effectiveness of vendor support.
• Track and maintain recruiting data, ensuring accuracy in systems such as Greenhouse and contributing to hiring metrics and reporting.
• Support execution of hiring plans in alignment with approved headcount and business priorities.
• Identify opportunities to improve recruiting processes, tools, and candidate experience.
• Stay informed on industry trends and talent market dynamics within biotech/pharma.
• Promote inclusive hiring practices and support efforts to mitigate bias in the recruiting process.
• Participate in special projects and broader Talent Acquisition or HR initiatives as needed.
• Other duties as assigned; this role offers opportunities to contribute to broader HR and organizational initiatives.

Qualifications

• Education: Bachelor’s degree or equivalent; HR Certification is a plus.
• Experience: 8+ years of full-cycle recruiting experience in biotech or pharmaceutical industry, as part of the internal talent acquisition team.
• Strong experience hiring of clinical roles; hiring of commercial roles is a plus.
• Proven ability to manage multiple requisitions across technical and business functions.
• Strong proficiency with recruiting systems and tools, including Greenhouse and LinkedIn Recruiter.
• Experience partnering with external search firms and staffing agencies.

Requirements

• Strong execution focus with the ability to manage multiple priorities in a fast-paced environment.
• Solid understanding of recruiting best practices and applicable employment laws.
• Ability to build effective partnerships with hiring managers and cross-functional stakeholders.
• Strong judgment and ability to handle confidential and sensitive information.
• Excellent communication, organization, and follow-through.
• Strong interpersonal skills and ability to influence without authority.

Benefits

• Hourly compensation range: $69.00 - $95.00.
• Please note, the hourly compensation range offered to the final candidate depends on various factors: candidate’s geographical location, relevant work experience, skills, and years of experience.

Company Description

4DMT is a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. The Company’s lead product candidate 4D-150 is designed to be a backbone therapy forming the foundation of treatment of blinding retinal vascular diseases by providing multi-year sustained delivery of anti-VEGF (aflibercept and anti-VEGF-C) with a single, safe, intravitreal injection, which substantially reduces the treatment burden associated with current bolus injections. The Company’s lead indication for 4D-150 is wet age-related macular degeneration, which is currently in Phase 3 development, and second indication is diabetic macular edema. The Company’s second product candidate is 4D-710, which is the first known genetic medicine to demonstrate successful delivery and expression of the CFTR transgene in the lungs of people with cystic fibrosis after aerosol delivery.